Clinical Trial Update: A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase II neoadjuvant radiotherapy followed by Ivonescimab and chemotherapy for locally advanced pMMR/MSS rectal adenocarcinoma; current status not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rectal Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING